Related Experiment Video
Updated: Mar 18, 2026
12:33
High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
Published on: November 15, 2013
48.7K
[Not Available]
Ghizlane Berrada El Azizi1, Samir Ahid1, Imane Ghannam1
1Équipe de Recherche de la Pharmacoépidémiologie et Pharmacoéconomie, Laboratoire de Pharmacologie et de Toxicologie, Faculté de Médecine et de Pharmacie, Université Mohammed V-Souissi, Rabat, Maroc.
Therapie
|July 10, 2016
Summary
Generic antihypertensive drug consumption significantly increased in Morocco from 1991-2010. This rise highlights the crucial role of generic medicines in improving healthcare access, particularly for vulnerable populations.
Area of Science:
- Pharmacoeconomics
- Public Health
- Pharmaceutical Policy
Context:
- The study examines the consumption trends of generic antihypertensive medications in Morocco between 1991 and 2010.
- It assesses the influence of Mandatory Health Insurance and generic drug marketing initiatives on consumption patterns.
Purpose:
- To evaluate the evolution of generic antihypertensive drug consumption over a 20-year period.
- To determine the impact of health insurance policies and generic drug availability on market dynamics.
Summary:
- Sales data revealed a significant rise in generic antihypertensive drug consumption, from 0.08 to 10.65 DDD/1000 inhabitants/day between 1991 and 2010.
- In 2010, generic calcium channel blockers (CCBs) were the most consumed (82.09%), followed by angiotensin-converting enzyme inhibitors (ACEIs) (48.29%).
- The CCB generics market dominated, accounting for 79.21% in volume and 62.58% in value in 2010.
Impact:
- Generic drugs are vital for enhancing treatment accessibility in developing nations like Morocco.
- The findings underscore the importance of generic medications in making essential therapies affordable for vulnerable populations.
